Header graphic for print

Shigella Blog

Surveillance & Analysis on Shigella News & Outbreaks

CDC Reports California Shigella Outbreak is Antibiotic Resistant

The CDC in MMWR, reports that in May 2012, the Los Angeles County Department of Public Health’s Acute Communicable Disease Control Unit and Environmental Health, Food, and Milk Program investigated an outbreak of shigellosis associated with a private bridge club. This investigation documented the first known transmission of Shigella sonnei with decreased susceptibility to azithromycin in the United States.

Cases were defined as an illness clinically compatible with shigellosis in a patient or S. sonnei isolated from stool of a person with an epidemiologic link to the bridge club during May 22–26, 2012. Investigators attempted to interview all bridge club workers and members who had visited the bridge club during the week of May 22; they collected stool specimens from workers who handled food and from workers and members with diarrhea who had not already submitted a stool specimen for culture at a health facility. Thirty-nine cases were identified among club members with diarrhea and four among club workers; of the four workers, two, including one who handled food, reported no symptoms. The average age of affected persons was 75.3 years (range: 54–98 years); 55% were female. Among those with symptoms, the duration of illness averaged 5.9 days (range: 1–14 days). Common symptoms included diarrhea in 95% of patients, abdominal cramps in 70%, and fever in 56%. Thirty-one (72%) persons sought medical care, and 10 (23%) were hospitalized. No specific exposures implicated a source for the outbreak.

Among the 43 cases, 14 were culture-confirmed; 10 isolates underwent pulsed-field gel electrophoresis (PFGE), yielding indistinguishable patterns. Four isolates submitted to CDC’s National Antimicrobial Resistance Monitoring System (NARMS) displayed resistance to streptomycin, sulfisoxazole, tetracycline, and trimethoprim-sulfamethoxazole. Unlike most Shigella isolates tested by NARMS, these isolates also showed elevated azithromycin minimum inhibitory concentrations (MICs) of >16 µg/mL and harbored a plasmid-encoded macrolide resistance gene, mphA.

CDC’s PulseNet identified two additional isolates indistinguishable from the outbreak PFGE pattern. One was from a man in Pennsylvania aged 23 years who had visited Los Angeles in April, and the other from a man in Hawaii aged 53 years who visited Los Angeles during April and May; both men were hospitalized with diarrhea. Neither case was epidemiologically linked to the bridge club or to each other.

Although sporadic cases of shigellosis caused by Shigella strains with increased azithromycin MICs have occurred, this is the first outbreak documented in the United States and might indicate increasing circulation of such strains. Illnesses in this outbreak tended to be severe; however, the affected population was much older than the general U.S. population. Clinical management of such illnesses is likely to be complex; although azithromycin currently is recommended for treatment of infections caused by multidrug-resistant Shigella, options for alternative treatment among children with such infections primarily include parenteral antimicrobial medications.

NIH-funded researchers begin trial of Shigella vaccine candidates – Aim to thwart a principal cause of diarrheal disease worldwide

Researchers have launched an early-stage human clinical trial of two related candidate vaccines to prevent infection with Shigella, bacteria that are a significant cause of diarrheal illness, particularly among children. The Phase I clinical trial, funded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, will evaluate the vaccines for safety and their ability to induce immune responses among 90 healthy adults ages 18 to 45 years. The trial is being conducted at the Cincinnati Children’s Hospital Medical Center, one of the eight NIAID-funded Vaccine and Treatment Evaluation Units in the United States.

Shigella infection, called shigellosis, is an intestinal disease spread via contact with infected feces, by consumption of contaminated food or water or by contact with a contaminated surface. Symptoms include diarrhea, abdominal pain, fever, nausea and vomiting. In healthy adults, the infection generally clears on its own in five to seven days, but if left untreated, can lead to hospitalization or death, especially among young children and adults with weakened immune systems.

According to the World Health Organization, shigellosis causes roughly 90 million cases of severe disease each year and 108,000 deaths, most of which occur in the developing world and affect children under 5 years of age. In the United States, 14,000 shigellosis cases are reported annually, with most cases occurring among children ages 1 to 4 years.

Antibiotics are the standard treatment for patients with shigellosis, but drug-resistant strains of the bacterium are becoming more common.

“It seems that Shigella bacteria know our immune system better than we do,” said William Alexander, Ph.D., a program officer in NIAID’s Enteric and Hepatic Diseases Branch, Division of Microbiology and Infectious Diseases. “They’ve become very good at evading the human immune response and causing significant illness, so developing vaccines and better treatments is critical.”

Led by principal investigator Robert W. Frenck, Jr., M.D., director of clinical medicine at Cincinnati Children’s, the new clinical trial will evaluate two related candidate vaccines, known as WRSs2 and WRSs3, which have been found to be safe and effective when tested in guinea pigs and nonhuman primates. Both target Shigella sonnei, one of the bacteria’s four subtypes and the cause of most shigellosis outbreaks in developed and newly industrialized countries. Though neither candidate vaccine has been tested in humans, a precursor to both, known as WRSs1, was found to be safe and generated an immune response in small human trials in the United States and Israel. This early work was supported by NIAID, the U.S. Department of Defense and the Walter Reed Army Institute of Research. All three versions of the vaccine were developed by researchers at the Walter Reed institute.

WRSs2 and WRSs3 are live, attenuated vaccines, which means that the bacteria they contain are weakened such that they do not cause illness but still can induce an immune response. The weakened versions of S. sonnei used in WRSs2 and WRSs3 cannot spread between human cells, limiting their ability to cause disease. They are designed to improve upon WRSs1 by reducing the mild diarrhea associated with that vaccine in some patients. In addition, WRSs3 is designed to reduce the fever that accompanied some WRSs1 vaccinations.

After undergoing informed consent, study participants will be split into 10 groups of eight participants each, with each group receiving an increasing dose of WRSs2 or WRSs3. The remaining 10 participants will receive placebo. All doses will be given orally and will be preceded with a sodium bicarbonate (baking soda) suspension to neutralize stomach acid, which prevents the bacteria in the vaccine from being killed too quickly. Immediately after vaccination, participants will be admitted to inpatient care. Eight days later, or sooner if serious shigellosis symptoms occur, participants will begin a course of antibiotics until they pass two consecutive stools that test negative for S. sonnei. During the hospital stay, which can last up to 13 days, participants will be closely monitored and receive physical exams several times daily. Once discharged, participants are expected to collect and supply a stool sample at follow-up physical exams on study days 14, 28 and 56.

Additional information about the clinical trial is available at http://www.ClinicalTrials.gov under the identifier NCT01336699.

NIAID conducts and supports research — at NIH, throughout the United States, and worldwide — to study the causes of infectious and immune-mediated diseases, and to develop better means of preventing, diagnosing and treating these illnesses. News releases, fact sheets and other NIAID-related materials are available on the NIAID website at http://www.niaid.nih.gov.

About the National Institutes of Health (NIH): NIH, the nation’s medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit http://www.nih.gov.

Shigella in Texas

Abilene Texas has seen a rise in Shigella cases since August, officials with the Abilene-Taylor County Public Health District report. Young children have been affected especially heavily.

Eighty cases have been reported since the first week of August, compared with about six cases per year on average.

A previous major outbreak occurred in 2002, when more than 200 cases were reported. By contrast, no cases were reported during 2010. Actual numbers will be higher, since not everyone experiences symptoms goes to a health care provider.

“Shigellosis is an infection of the intestines that causes diarrhea,” the report reads. “It is usually a mild, self-resolving illness (meaning the body will fight off the infection without treatment), and most people recover completely within 4 to 7 days.

Shigella is highly contagious and often begins with a victim swallowing something contaminated by the feces of an infected person. This usually happens when the infected person fails to properly wash hands after a bowel movement, then touches the hands or food of another person. Even a person without symptoms can pass on the bacteria.

Prevention methods include:

  • Hand-washing after bathroom visits, diaper changes or handling of pets or soil. Hands should be washed for at least 20 seconds using running water and soap. Hand sanitizer may be used as a substitute.
  • Children should wash hands frequently, with young children doing so under adult supervision.
  • Washing hands after diaper changes is especially important if the child has diarrhea.

More Shigella in Ohio

Columbus health officials are investigating what they call an “unprecedented large number of Shigella illness” in the area.

Since the start of the outbreak, 771 cases have been diagnosed.

That’s the largest number of cases in any year in the last decade.

Shigella is a bacterium that causes an infection of the intestine called Shigellosis. It causes diarrhea which may be bloody, and can cause severe dehydration and hospitalization. Found in human feces, this bacterium can get on hands when using the toilet or changing diapers.

Wisconsin Shigella Outbreak

Dane County health officials are dealing with an outbreak of bacterial infection.

Eighteen cases of Shigellosis have been reported in the county since Sept. 20. That’s one fewer case than all of last year.

The bacterial infection is associated with consuming water or food contaminated with fecal matter. Most of the Dane County cases are in children and young adults. Only one person sickened has been older than 40.

Shigella Strikes Ohio

A bacterial illness is plaguing day-care centers in central Ohio, and health officials warn it could spread if parents aren’t vigilant.

The Columbus Dispatch reports Wednesday that the number of reported cases of shigella more than doubled in September in Franklin County, which includes Columbus. There have been 435 cases, compared with reported numbers in the teens the past two years.

The disease causes diarrhea and is easily spread if care isn’t taken when changing diapers, preparing food and cleaning up after bathroom breaks.

Dr. Mysheika Roberts, Columbus Public Health’s medical director, says there have been confirmed cases of shigella at 30 day-care centers in the city this year.

Shigella in Ohio

Misti Crane of the Columbus Dispatch – Columbus and Franklin County health officials are warning day-care providers to take precautions against spreading a bacterial infection that causes diarrhea and can be especially harmful to people with weak immune systems.

Shigella cases are on the increase in the county, especially in the city, and most have been linked to day-care providers where more than one child has been infected, said Columbus Public Health medical director Mysheika Roberts.

There have been 144 known cases this year, many of those in the past few weeks, and most in children younger than 4.

Omaha Shigella Increase Prompts Health Department Warning

Since May, the Douglas County Health Department has investigated 50 confirmed cases of Shigella sonnei (shigellosis) infection, including four that involved hospitalizations. In eight of the nine previous years, Douglas County reported 31 or fewer cases.

Symptoms of shigellosis can range from loose, watery stools with no other symptoms to bloody diarrhea with fever and cramps. People experiencing diarrhea should remain home from school or work until at least 24 hours after their symptoms stop. Anyone with diarrhea should not prepare food or drink for others.

“Hand washing is absolutely critical to controlling any disease that involves diarrhea,” Health Director Dr. Adi Pour said. “It is especially important to wash your hands with soap for at least 20 seconds after changing diapers or using the bathroom, since it takes only a small exposure to pass along the disease.”

Forty-one percent of these recent shigellosis cases involved children less than 5 years old and 29 percent were between 5 and 9 years old. Most of the cases, 62 percent, have been associated with child care settings.

It is also important for anyone who has been sick to stay out of swimming pools and water parks for a week after they have recovered. Most of the recent Douglas County cases are linked to day care facilities, but swallowing pool water is another way shigellosis may be transmitted.

Florida Shigella Cases Spike

jpgThe Okaloosa County Health Department (OCHD) is reporting an increase in Shigella cases county-wide, with 49 laboratory confirmed and probable cases since the beginning of this year. Since 2000, Okaloosa County has averaged 3 cases of Shigella per year (range 0 – 7). The health department has been working diligently to implement prevention and control measures with child care centers, community health care providers, congregate living facilities, and the Department of Children and Families.

Shigella is a group of bacterial that causes shigellosis. Shigellosis is usually a mild, self-resolving diarrheal illness (meaning the body will fight off the infection without treatment). Most people recover completely within 4 to 7 days. After a person is infected, symptoms may develop within 1 to 3 days. The diarrhea is watery and sometimes bloody. Other symptoms include nausea, vomiting, abdominal pain, and fever. Some people never develop any symptoms after being infected.